SEATTLE, Aug. 14, 2018 (GLOBE NEWSWIRE) — CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Sproutly Canada, Inc.’s (CSE: SPR) recent acquisition of Infusion Biosciences Canada and its water-soluble cannabinoid technology. The company has discovered naturally occurring versions of cannabinoids, […]

DENVER, Aug. 14, 2018 /PRNewswire/ — CBx Sciences, a CBx Enterprises brand, today announced the availability of its new Gems product line. Based on proven pharmaceutical delivery technology formulated by CBx Sciences Chief Scientist, Noel Palmer, Ph.D., Gems are small, discreet, lightly flavored lozenges that transmucosally deliver doses of potent cannabinoids, terpenes and complementary botanicals. […]

Posted in: Medical Science News | Medical Research News | Pharmaceutical News Tags: Brain, Caffeine, Cannabinoid, Cannabis, Chronic Pain, Drugs, Epilepsy, Imaging, Mental Health, Multiple Sclerosis, Nervous System, Pain, Psychosis, Receptor, Research, Schizophrenia, Sclerosis …read more at https://www.news-medical.net/news/20180813/Long-term-cannabinoid-exposure-impairs-memory-study-shows.aspx

…read more at https://qns.com/story/2018/08/13/check-astoria-restaurant-serving-cannabinoid-infused-drinks-munchies/

by Deborah Mitchell, Naturally Savvy New research indicates that a synthetic cannabinoid has proved successful in treating sleep apnea, a condition that affects approximately 22 million Americans. If you or someone you know has this sleep condition, you probably know how challenging it can be to treat it and the impact it can have on daily […]

Medical cannabis has been all the rage in the UK of late.  Headlines about two young epilepsy sufferers, Billy Caldwell and Alfie Dingely, who were denied access to cannabis oil that helped keep their conditions under control, sparked a debate that led to the home secretary Sajid Javid’s decision to allow medical cannabis to be available […]

The Korean Cannabinoid Association (KCA) said at a conference in Seoul on Monday that it intended to initiate a project to carry out clinical pilots related to cannabidiol (CBD), a constituent of cannabis that is used in multiple sclerosis and epilepsy therapies among others. The KCA will launch the project via Prasm, a decentralized bioinformatic […]

CLOSE CURE Pharmaceutical of Oxnard manufactures a sachet that contains an oral thin film strip used to deliver medication through a patient’s skin or mouth. Chuck Kirman, Ventura County Star Buy Photo Steven Ruhl, vice president of manufacturing at CURE Pharmaceutical, displays a finished sachet that contains an oral thin film strip. The thin film […]

Medical cannabis has been all the rage in the UK of late.  Headlines about two young epilepsy sufferers, Billy Caldwell and Alfie Dingely, who were denied access to cannabis…read more at https://www.standard.co.uk/tech/oxford-cannabinoid-technologies-medical-cannabis-a3905676.html

Medical cannabis has been all the rage in the UK of late.  Headlines about two young epilepsy sufferers, Billy Caldwell and Alfie Dingely, who were denied access to cannabis oil that helped keep their conditions under control, sparked a debate that led to the home secretary Sajid Javid’s decision to allow medical cannabis to be available […]

Medical cannabis has been all the rage in the UK of late.  Headlines about two young epilepsy sufferers, Billy Caldwell and Alfie Dingely, who were denied access to cannabis oil that helped keep their conditions under control, sparked a debate that led to the home secretary Sajid Javid’s decision to allow medical cannabis to be available […]

Auscann Group Holdings Ltd (ASX:AC8) has raised about $1.9 million from shareholders via a share purchase plan (SPP) at an issue price of $1.05 per share. The SPP follows a share placement to institutional and sophisticated investors which raised about $33.4 million. READ: AusCann Group secures $33.4 million to fund ambitious medicinal cannabis future AusCann […]

Proactive Investors contributor Bob Byrne tells Proactive’s Christine Corrado he’s impressed by CV Sciences (OTCQB: CVSI), as the $289 million life sciences company has reported record sales, gross profit, and net income. Byrne says the stock is already up more than 400% on a year-to-date basis, but given the company’s incredible financial performance and its […]

This pioneering research article explains the benefits of cannabinoid-based medicines for heart disease therapies based on scientific research. LAS VEGAS, Aug. 2, 2018 /PRNewswire/ – GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the publication of a review article co-authored by GB Sciences and key collaborators in the Journal of the American Heart Association, which […]

RAMAT GAN, Israel, August 1, 2018 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced today the initiation of the final stage of its Phase I, placebo controlled, maximal dose study (the “Psoriasis Study”) to determine the safety and tolerability of […]